Biotech Legislative Agenda: Healthcare, Energy, Patents And Capital
The United States Congress and biotechnology industry are currently focused on healthcare reform, but biotech is also looking to the future at energy reform, patent reform and other intellectual property-related legislative priorities still on its agenda.

The third amendment of Chinese Patent Law enters into force from 1 October, 2009. This article by Wenting Cheng explores the major changes in substantive requirements for patent grant, post-grant enforcement and adaptation of Chinese Patent Law to international norms on the protection of intellectual property.